The experts on AuzBiz just recommended this as a buy. What was clear from the discussion is that neither knew about the company before and also after their research for the show they still didn't know that much about it. They just focused on the dental gel and FDA approval and possible market with no discussion on the nerve growth possibilities. As suspected the company just isn't very good at marketing itself and the upside the products offer. Until this is fixed I suspect we wont get major bounces until there is news rather than on the fundamentals.
FDA significance, page-324
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
62.0¢ |
Change
-0.010(1.59%) |
Mkt cap ! $148.2M | |||
| Open | High | Low | Value | Volume |
| 64.5¢ | 66.0¢ | 61.0¢ | $621.5K | 991.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 63281 | 61.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 62.0¢ | 9344 | 1 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| OCC (ASX) Chart |